Pediatric Hodgkin Lymphoma: Maximizing Efficacy and Minimizing Toxicity
To access this article, please choose from the options below
PII: S1053-4296(07)00020-3
doi:10.1016/j.semradonc.2007.02.009
© 2007 Elsevier Inc. All rights reserved.
PII: S1053-4296(07)00020-3
doi:10.1016/j.semradonc.2007.02.009
© 2007 Elsevier Inc. All rights reserved.